Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 14 | 2024 | 202 | 7.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 27 | 2025 | 374 | 4.430 |
Why?
|
| Microbiota | 6 | 2024 | 104 | 3.590 |
Why?
|
| Dysbiosis | 7 | 2024 | 56 | 2.990 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 560 | 2.670 |
Why?
|
| Frailty | 4 | 2022 | 126 | 2.450 |
Why?
|
| Feces | 6 | 2024 | 97 | 2.430 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 737 | 2.040 |
Why?
|
| Soft Tissue Infections | 4 | 2020 | 45 | 1.750 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 83 | 1.720 |
Why?
|
| Emergency Service, Hospital | 14 | 2025 | 1039 | 1.690 |
Why?
|
| Nursing Homes | 6 | 2024 | 672 | 1.350 |
Why?
|
| Clostridium Infections | 2 | 2021 | 47 | 1.230 |
Why?
|
| Metagenomics | 3 | 2024 | 22 | 1.170 |
Why?
|
| Aging | 2 | 2024 | 731 | 1.080 |
Why?
|
| Aged | 23 | 2024 | 13581 | 1.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 34 | 0.970 |
Why?
|
| Humans | 68 | 2025 | 60132 | 0.970 |
Why?
|
| Diarrhea | 2 | 2016 | 73 | 0.960 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 87 | 0.960 |
Why?
|
| Cognitive Dysfunction | 3 | 2024 | 276 | 0.940 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 144 | 0.900 |
Why?
|
| Male | 37 | 2025 | 27971 | 0.850 |
Why?
|
| Female | 39 | 2025 | 31250 | 0.830 |
Why?
|
| Influenza, Human | 3 | 2014 | 192 | 0.820 |
Why?
|
| Guideline Adherence | 3 | 2020 | 298 | 0.790 |
Why?
|
| Inflammation | 4 | 2024 | 1110 | 0.750 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 79 | 0.750 |
Why?
|
| Prospective Studies | 13 | 2025 | 3131 | 0.740 |
Why?
|
| Treatment Failure | 3 | 2021 | 189 | 0.730 |
Why?
|
| Adult | 31 | 2025 | 15985 | 0.730 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 18 | 0.720 |
Why?
|
| Bacteria | 4 | 2024 | 278 | 0.660 |
Why?
|
| Polysaccharides | 1 | 2021 | 147 | 0.660 |
Why?
|
| Skin Diseases, Infectious | 2 | 2016 | 10 | 0.660 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 67 | 0.640 |
Why?
|
| Depressive Disorder, Major | 4 | 2023 | 260 | 0.620 |
Why?
|
| Middle Aged | 25 | 2025 | 16535 | 0.600 |
Why?
|
| Longitudinal Studies | 13 | 2025 | 1237 | 0.590 |
Why?
|
| Macrolides | 1 | 2018 | 38 | 0.590 |
Why?
|
| Antacids | 1 | 2017 | 13 | 0.580 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 88 | 0.570 |
Why?
|
| Independent Living | 1 | 2017 | 47 | 0.560 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 685 | 0.560 |
Why?
|
| Bacterial Infections | 2 | 2023 | 139 | 0.560 |
Why?
|
| Nutritional Status | 1 | 2017 | 119 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 2049 | 0.530 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 157 | 0.520 |
Why?
|
| Aged, 80 and over | 9 | 2024 | 5197 | 0.520 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 5 | 0.500 |
Why?
|
| Outpatients | 1 | 2016 | 140 | 0.500 |
Why?
|
| Young Adult | 16 | 2025 | 4396 | 0.490 |
Why?
|
| Hyphae | 1 | 2014 | 13 | 0.480 |
Why?
|
| Mediator Complex | 1 | 2014 | 13 | 0.480 |
Why?
|
| Neoplasms | 1 | 2025 | 1261 | 0.470 |
Why?
|
| Candida albicans | 1 | 2014 | 54 | 0.460 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 19 | 0.460 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 61 | 0.460 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 77 | 0.460 |
Why?
|
| Reward | 2 | 2024 | 84 | 0.450 |
Why?
|
| Fungal Proteins | 1 | 2014 | 142 | 0.450 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 305 | 0.440 |
Why?
|
| Fear | 2 | 2025 | 67 | 0.440 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 80 | 0.430 |
Why?
|
| Heart Rate | 2 | 2024 | 308 | 0.410 |
Why?
|
| Wearable Electronic Devices | 2 | 2024 | 65 | 0.410 |
Why?
|
| White Matter | 2 | 2024 | 114 | 0.410 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 305 | 0.390 |
Why?
|
| Machine Learning | 3 | 2024 | 150 | 0.390 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 151 | 0.390 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 168 | 0.380 |
Why?
|
| Virus Diseases | 1 | 2012 | 112 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 719 | 0.370 |
Why?
|
| Cohort Studies | 5 | 2024 | 2479 | 0.360 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1471 | 0.340 |
Why?
|
| Amygdala | 3 | 2024 | 81 | 0.330 |
Why?
|
| Prefrontal Cortex | 3 | 2024 | 115 | 0.330 |
Why?
|
| Wrist | 3 | 2024 | 32 | 0.320 |
Why?
|
| Cytokines | 1 | 2013 | 911 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 712 | 0.310 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 243 | 0.310 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 87 | 0.310 |
Why?
|
| Biomarkers | 3 | 2024 | 1213 | 0.310 |
Why?
|
| Brain | 7 | 2024 | 1493 | 0.300 |
Why?
|
| Depression | 7 | 2023 | 868 | 0.300 |
Why?
|
| Risk Factors | 7 | 2024 | 5082 | 0.300 |
Why?
|
| Pain | 3 | 2023 | 406 | 0.290 |
Why?
|
| Health Personnel | 2 | 2021 | 343 | 0.290 |
Why?
|
| Motor Vehicles | 6 | 2023 | 37 | 0.290 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2024 | 68 | 0.260 |
Why?
|
| Psychological Trauma | 2 | 2024 | 21 | 0.250 |
Why?
|
| Prognosis | 3 | 2025 | 1591 | 0.250 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 23 | 0.240 |
Why?
|
| Autonomic Nervous System | 1 | 2025 | 32 | 0.240 |
Why?
|
| ROC Curve | 3 | 2021 | 260 | 0.240 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.240 |
Why?
|
| Marijuana Use | 1 | 2025 | 18 | 0.240 |
Why?
|
| Tobacco Use | 1 | 2025 | 37 | 0.240 |
Why?
|
| Mouth | 1 | 2024 | 32 | 0.240 |
Why?
|
| Metabolomics | 1 | 2024 | 52 | 0.230 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 57 | 0.220 |
Why?
|
| Estradiol | 1 | 2025 | 244 | 0.220 |
Why?
|
| Income | 1 | 2025 | 162 | 0.220 |
Why?
|
| Massachusetts | 3 | 2024 | 2118 | 0.220 |
Why?
|
| Gray Matter | 1 | 2023 | 29 | 0.220 |
Why?
|
| Internal Capsule | 1 | 2023 | 12 | 0.210 |
Why?
|
| Longevity | 1 | 2024 | 112 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 928 | 0.210 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 13 | 0.210 |
Why?
|
| Residence Characteristics | 1 | 2024 | 229 | 0.210 |
Why?
|
| Computational Biology | 1 | 2025 | 332 | 0.210 |
Why?
|
| Biological Availability | 1 | 2023 | 194 | 0.210 |
Why?
|
| Dreams | 1 | 2022 | 3 | 0.210 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 7 | 0.200 |
Why?
|
| Prevalence | 3 | 2021 | 1300 | 0.200 |
Why?
|
| Cannabis | 1 | 2023 | 47 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2024 | 197 | 0.200 |
Why?
|
| Acute Pain | 1 | 2022 | 20 | 0.200 |
Why?
|
| Smartphone | 1 | 2023 | 64 | 0.200 |
Why?
|
| Sex Factors | 3 | 2025 | 969 | 0.200 |
Why?
|
| Logistic Models | 2 | 2016 | 1259 | 0.190 |
Why?
|
| Child Abuse | 1 | 2023 | 87 | 0.190 |
Why?
|
| Social Support | 1 | 2024 | 366 | 0.190 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 15 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2024 | 522 | 0.190 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 13 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 157 | 0.180 |
Why?
|
| Human Development | 1 | 2020 | 9 | 0.180 |
Why?
|
| Abscess | 1 | 2021 | 75 | 0.180 |
Why?
|
| Drainage | 1 | 2021 | 150 | 0.180 |
Why?
|
| Health | 1 | 2020 | 32 | 0.180 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 38 | 0.180 |
Why?
|
| Adolescent | 6 | 2023 | 5958 | 0.180 |
Why?
|
| Virus Replication | 1 | 2002 | 307 | 0.180 |
Why?
|
| Monocytes | 1 | 2002 | 345 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 69 | 0.170 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 8 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2021 | 258 | 0.170 |
Why?
|
| Psychometrics | 1 | 2021 | 359 | 0.170 |
Why?
|
| Diet | 1 | 2024 | 637 | 0.160 |
Why?
|
| Anxiety | 4 | 2023 | 400 | 0.160 |
Why?
|
| Animals | 6 | 2024 | 19768 | 0.160 |
Why?
|
| Self Care | 1 | 2021 | 212 | 0.160 |
Why?
|
| Occupational Diseases | 1 | 2021 | 266 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 74 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2021 | 306 | 0.150 |
Why?
|
| Survivors | 3 | 2024 | 148 | 0.150 |
Why?
|
| Intestines | 1 | 2019 | 156 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2505 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2087 | 0.140 |
Why?
|
| Paracentesis | 1 | 2016 | 12 | 0.140 |
Why?
|
| HIV-1 | 1 | 2002 | 709 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 376 | 0.130 |
Why?
|
| Homeostasis | 1 | 2019 | 343 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 121 | 0.130 |
Why?
|
| Age Distribution | 1 | 2016 | 262 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 691 | 0.130 |
Why?
|
| Recurrence | 1 | 2017 | 600 | 0.130 |
Why?
|
| Dementia | 1 | 2019 | 252 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 406 | 0.130 |
Why?
|
| Telemedicine | 1 | 2021 | 336 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1100 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 470 | 0.120 |
Why?
|
| HIV Infections | 1 | 2002 | 927 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1066 | 0.120 |
Why?
|
| United States | 4 | 2021 | 7622 | 0.120 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 9 | 0.120 |
Why?
|
| Algorithms | 1 | 2020 | 1002 | 0.120 |
Why?
|
| Virulence | 1 | 2014 | 189 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2021 | 770 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2014 | 112 | 0.110 |
Why?
|
| HLA-DR3 Antigen | 1 | 2013 | 6 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 123 | 0.110 |
Why?
|
| Femoral Nerve | 1 | 2013 | 5 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 292 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2014 | 345 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 52 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2017 | 688 | 0.100 |
Why?
|
| Psychopathology | 2 | 2023 | 20 | 0.100 |
Why?
|
| Nerve Block | 1 | 2013 | 42 | 0.100 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 178 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 209 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 88 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 191 | 0.100 |
Why?
|
| Hip Fractures | 1 | 2013 | 79 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 774 | 0.100 |
Why?
|
| Trauma Centers | 1 | 2012 | 119 | 0.090 |
Why?
|
| Pain Management | 1 | 2013 | 152 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1525 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 577 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6139 | 0.090 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 190 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5262 | 0.090 |
Why?
|
| Neuroimaging | 2 | 2022 | 131 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 910 | 0.090 |
Why?
|
| Disease Progression | 1 | 2014 | 1054 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 251 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1035 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 621 | 0.080 |
Why?
|
| Cognition | 2 | 2024 | 466 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1315 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 424 | 0.080 |
Why?
|
| Paecilomyces | 1 | 2008 | 2 | 0.080 |
Why?
|
| Bursitis | 1 | 2008 | 12 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 41 | 0.070 |
Why?
|
| Mutation | 1 | 2014 | 2471 | 0.070 |
Why?
|
| Child | 3 | 2022 | 4336 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1227 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2021 | 460 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2025 | 8 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 7 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2024 | 119 | 0.060 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.060 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.060 |
Why?
|
| Bacteroides | 1 | 2023 | 9 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2023 | 44 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 508 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 59 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 48 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 353 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 93 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 57 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 253 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 10343 | 0.050 |
Why?
|
| Hippocampus | 1 | 2024 | 243 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 792 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 94 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 94 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 31 | 0.050 |
Why?
|
| Biological Variation, Individual | 1 | 2021 | 3 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 6 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 34 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 449 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 38 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 46 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 83 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 20 | 0.050 |
Why?
|
| Comorbidity | 1 | 2025 | 1098 | 0.050 |
Why?
|
| Life Change Events | 1 | 2021 | 66 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 455 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 369 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 229 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 387 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 344 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 498 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 223 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 218 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 97 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1470 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 371 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2616 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1937 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 44 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 18 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 257 | 0.030 |
Why?
|
| New England | 1 | 2013 | 268 | 0.030 |
Why?
|
| Analgesia | 1 | 2013 | 33 | 0.030 |
Why?
|
| Viral Load | 1 | 2013 | 229 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 161 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 729 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2013 | 524 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1531 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 842 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 8 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2008 | 4 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 97 | 0.020 |
Why?
|